DEUTERATED COMPOUNDS AND USES THEREOF
The present invention provides for the treatment, prevention, and/or reduction of a risk of a disease, disorder, or condition in which aldehyde toxicity is implicated in the pathogenesis, including ocular disorders, skin disorders, conditions associated with injurious effects from blister agents, an...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
25.04.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides for the treatment, prevention, and/or reduction of a risk of a disease, disorder, or condition in which aldehyde toxicity is implicated in the pathogenesis, including ocular disorders, skin disorders, conditions associated with injurious effects from blister agents, and autoimmune, inflammatory, neurological and cardiovascular diseases by the use of a primary amine to scavenge toxic aldehydes, such as MDA and HNE. |
---|---|
Bibliography: | Application Number: US202318504672 |